Week In Review: Broncus Stages $200 Million Hong Kong IPO For Pulmonary Devices
September 25, 2021 at 14:45 PM EDT
Broncus Holding, a Hangzhou pulmonary medical device company, completed a $200 million IPO on the Hong Kong exchange that valued the company at nearly $1.3 billion. The IPO was priced at the top end of the range, but Broncus' shares dropped 20%.
